Vertaling van "mortality in high-risk primary prevention " (Frans → Nederlands) :

Discussion de: Ray KK, Seshasai SRK, Erqou S et al. Statins and all-cause mortality in high-risk primary prevention.
Kaess BM, Vasan RS. Statins are not associated with a decrease in all cause mortality in a high-risk primary prevention setting.

Analyse de: Bjelakovic G, Nikolova D, Gluud LL et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.
Bespreking van: Bjelakovic G, Nikolova D, Gluud LL et al. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis.

29. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery.
30. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery.

Analyse de: Tonelli M, Lloyd A, Clement F et al. Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis.
Bespreking van: Tonelli M, Lloyd A, Clement F et al. Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis.